Despite the above difficulties and challenges in targeting WDHD1 therapies, however, we believe that with the continuous development of precision medicine and the growing understanding of the association of WDHD1 biology with cancer, more WDHD1 inhibitors will be integrated into a mechanistically richer and larger pipeline of targeted drugs. Here, WDHD1 is linked to cancer.